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ADDING TRIAMCINOLONE TO VISCOSUPPLEMENTATION: ONE YEAR
OUTCOME OF RANDOMIZED TRIAL
G.C. Campos, M.U. Rezende, R. Fruchi, T. Pasqualin, M.I. Hissadomi. IOT
– FMUSP, S~ao Paulo, Brazil
Purpose: This is an extended follow up of a randomised controlled trial
to evaluate if the addition of triamcinolone to viscosupplementation
could alter one-year pain and function of viscosupplementation alone.
Methods: We prospectively enrolled 104 patients with knee osteo-
arthritis and randomized them to receive either a single intraarticular
injection (6 mL) of hylan GF-20 (Group viscosupplementation [Group
VS]), or a single intraarticular injection of hylan GF-20 (6 mL) and 1 mL
(20mg) of triamcinolone hexacetonide (Group VSþT). VAS,WOMACTM,
and Lequesne questionnaires were completed at baseline, at weeks 1, 4,
12, 24 and at one year.
Results: At week 1 the WOMAC and VAS scores were lower in Group
VSþT, compared with Group VS. There was no difference regarding the
adverse effects. At weeks 4, 12, 24 and one year there were no differ-
ences within the groups. At one year only Group VSþT still showed a
difference from baseline for VAS.
Conclusions: The addition of triamcinolone hexacetonide improves
ﬁrst-week symptom and functional scores of viscosupplementation and
does not alter its adverse effects. There might be beneﬁts for the one
year pain results.
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LONG-TERM EFFECT OF A FLEXIBLE MINIMALIST SHOE ON ALGO-
FUNCTIONAL, ANALGESIC MEDICATION INTAKE AND GAIT
KINEMATIC IN ELDERLY WOMEN WITH KNEE OSTEOARTHRITIS
A. Matias, F. Trombini-Souza, M. Yokota, I. Pereira, C. Schainberg,
R. Fuller, I.C. Sacco. Univ. of Sao Paulo, Sao Paulo, Brazil
Purpose: To evaluate the therapeutic effect of a minimalist and inex-
pensive footwear on pain, function, gait kinematics and paracetamol
intake in elderly women with knee OA.
Methods: A randomized, parallel and controlled clinical trial, with blind
assessor was carried out. Fifty-six elderly women with knee OA graded
2 or 3 (Kellgren and Lawrence) were randomly allocated into the
intervention group (IG, n ¼ 28) or the control group (CG, n ¼ 28) and
assessed at baseline (T0), after three (T3) and after six months of
intervention (T6). The IG patients should wear the minimalist shoes
(Moleca) for at least 6-hours daily. Moleca shoe (Calçados Beira Rio
S.A., Novo Hamburgo, RS, Brazil) is awomen’s double canvas ﬂexible ﬂat
walking shoe without heels, with a 5-mm anti-slip rubber sole. The CG
could not wear these shoes or any other similar, as well as be under
physical therapy or acupuncture treatment for the knee OA throughout
these 6-months. Paracetamol intake (500 milligrams) for every 6 hour
was allowed for both groups only in extreme pain situation. The out-
comes of the study were: Lequesne algo-functional score, paracetamol
intake, and lower limb kinematics while walking. The time effects (T0,
T3 and T6), group (IG and CG) and interaction (time vs. group) were
tested by two-way casewise ANOVA.
Results: The IG wore the Moleca shoe for an average monthly of 7h40
a day, achieving improvement of 35% in Lequesne algo-functional score
at T3 (p< 0.001; large within-group effect size: 1.07) and 43% at T6 (p<
0.001; large within-group effect size: 1.31). In CG, there was an
improvement of 23% at T3 (p < 0.001; moderate within-group effect
size: 0.71) and 16% at T6 (p < 0.001; moderate within-group effect size:
0.45). From T3 to T6, the CG got worse in the Lequesne algo-functional
score in 8.9%, while the IG showed an improvement throughout the 6-
months. The CG signiﬁcantly increased the rescue medication intake
throughout the trial, which possibly resulted in their algo-functional
improvement. The IG, on the other hand, showed just a slightly increase
in the paracetamol intake at the end of the 1st, 2nd and 3rd months.
However, at 4th, 5th and 6th months, the paracetamol intake was again
similar to the baseline status. From the 2nd to 6th month, this practice
was signiﬁcantly higher in CG compared to IG. Although the IG patients
have achieved a higher improvement in algo-functional aspect of the
disease, and a reduction in rescue medication intake, there was no
interaction effect for: knee early ﬂexion (p¼ 0.293), knee ﬁnal ﬂexion (p
¼ 0.742), knee extension (p¼ 0.337), and sagittal range of the knee (p¼
0.417).
Conclusion: The results suggests that the usage of Moleca shoe can be
considered as a conservative treatment of knee OA to improve the algo-functional aspects and to reduce the analgesic medication intake,
keeping unchanged the kinematics of the knee during gait.
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FORCE PLATFORM ANALYSIS OF THE EFFECT OF INTRARTICULAR
INJECTION OF AUTOLOGOUS ADIPOSE-DERIVED MESENCHYMAL
STEM CELLS ASSOCIATED TO PRGF IN OSTEOARTHRITIC DOGS
M. Rubio Zaragoza y,z, B. Cuervo Serrato y,z, J.M. Carrillo Poveda y,z,
J.J. Sopena Juncosa y,z, R. Cugat Bertomeu x,z, M. Garcia Balletbo x,z,
M. Morales Fari~na k, J.M. Vilar Guere~no k. yUniv. CEU Cardenal Herrera,
Alfara del Patirarca, Spain; zGarcia Cugat Fndn. CEU-UCH Chair of Med.
and Regenerative Surgery, Valencia, Spain; xArtroscopia GC, Barcelona,
Spain; kUniv. Las Palmas de Gran Canaria, Las Palmas de Gran Canaria,
Spain
Purpose: Adipose-derived mesenchymal stem cell (aMSC) therapy
in regenerative medicine is a rapidly growing area of research and
is currently also being used to treat osteoarthritis (OA). Force
platform analysis has been consistently used to verify the efﬁcacy
of different therapeutic strategies for the treatment of OA in dogs,
but never with aMSC. Recent investigations have shown that
growth factors contained in platelet-rich plasma (PRGF) act as
vehicles and even potentiators of the effect of aMSCs. The purpose
of this study was to use force platform kinetic analysis to evaluate
the effect of a single intraarticular injection of aMSC in 8 dogs with
OA of hip joints by measuring peak vertical force (PVF) and vertical
impulse (VI), which represent maximal weight bearing and dis-
tribution of forces through time, respectively.
Methods: Eight adult client-owned Canarian Presa dogs (5 males, 3
females) with OA were inﬁltrated with aMSC and PRGF. Dog owners
were informed and granted a signed consent for the whole proce-
dure. Stem cell extraction and inoculation phases were performed
under general anesthesia (sevoﬂurane). The adipose tissue (inguinal
region) was processed using the Dog Stem (Fat-Stem) protocol. The
number of mesenchymal stem cells was over 30 million, certiﬁed
with a laboratory certiﬁcate for the quality of the cells and received
in two 2 ml tubes with 15 million per tube. Once the aMSC were
received they were inﬁltrated with the PRGF-Endoret that was
prepared in that moment (centrifuged during 8 minutes at 460 G
and activated with 5% of its volume with 10% calcium chloride). The
resultant 4 ml solution was injected aseptically into the hip joints
through conventional artrocenthesis sites. Gait analysis was per-
formed using a single platform mounted in the center of, and level
with, a 7-m runway covered by a rubber mat. The mat weight was
discarded setting to “0 force” with the tare button after the platform
was covered. Dogs were leash guided at walk over the force plat-
form by the same handler. Walk velocity was measured by use of a
motion sensor (Pasco, California, USA) positioned 1 m apart from the
platform. Five valid trials, at a sampling frequency of 250 Hz, were
obtained for each dog. A member of the research team evaluated the
trial to conﬁrm which limb touched the center of the force platform.
The platform was interfaced with a dedicated computer using
DataStudio. Data were recorded from both affected limbs at day 0,
30, 90, and 180 post-treatment; the obtained PVF and VI values were
normalized relative to body weight (%) to characterize the possible
improvement of lameness during treatment with aMSCs. Data were
analyzed with a linear mixed effects model for a blocked design with
repeated measures. The time and the lame-sound of the dog were
considered as ﬁxed effects factors, while the dog was a random
effects factor. Signiﬁcance of the differences in PVF and VI between
periods of observation was tested by means of analysis of variance of
these models, with a post-hoc Tukey’s test. For assessing the rela-
tionships between supporting force in the more-lame and the less-
lame limbs and also between vertical impulses in the two limbs, a
regression model with random effects of dog on slope and intercept
was used. Signiﬁcance level was set at P  0.05 in all tests.
Results: Eight lame dogs with severe hip OA and a control group of 5
sound dogs were used for this study. Results were statistically analyzed
to detect a signiﬁcant increase in peak vertical force (PVF) and vertical
impulse (VI) in treated dogs. Mean values of PVF and VI were sig-
niﬁcantly improved after treatment of the OA groups, reaching 53.02%
and 14.84% of bodyweight, respectively, at day 180, comparedwith only
43.56% and 12.16% at day 0.
Conclusions: This study objectively demonstrated that intraarticular
aMSC therapy resulted in reduced lameness due to OA.
Ages (yrs) Mechanism of
Injury
Prior Knee Surgery Contra lateral
Knee Status
Ipsilateral Contralateral
12–33 Playing a sport No No Normal
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MOON-AAA GCP CLINICAL TRIAL: EARLY LESSONS FROM AN EARLY
INTERVENTIONAL TRIAL IN PATIENTS WITHIN 1 WEEK AFTER ACL
TEAR
C. Lattermann y, M. Profﬁtt y, V.B. Kraus z, K.P. Spindler x. yUniv. of
Kentucky, Lexington, KY, United States; zDuke Univ., Durham, NC, United
States; xCleveland Clinic Fndn., Cleveland, OH, United States
Posttraumatic Osteoarthritis (PTOA) often results from knee ligament
injuries such as to the anterior cruciate ligament (ACL). Patients with ACL
injuries are a unique population the initiation event for the development
of PTOA is often known. Enrolment of these patients and the prospective
collection of “early” information on this population is challenging as the
majority in the USwill not be seen by a specialist until severalweeks after
injury. We here describe the early lessons learned from the “Multicenter
Orthopaedic Outcome Network Early-Anti-inﬂammatory Treatment in
Patients with Acute ACL Tear and Painful Effusions” (MOON-AAA) clinical
trial. This is the ﬁrst US-based multicenter, randomized, good clinical
practices (GCP) interventional clinical trial recording biomarker proﬁles,
standardized X-rays as well as patient reported outcomes (PRO’s) in iso-
lated ACL tears seen within 4 days after ACL injury.
Methods: This is a GCP multicenter clinical trial enrolling patients with
primary isolated ACL tears within 4 days after injury. Inclusion criteria
follow the MOON -protocol (Table 1). All patients undergo aspiration of
the post-injury effusion within 4 days and 10 days post-injury. Patients
receive an injection with 40 mg Kenalog within 4 days, 10 days, both
time points or not at all (saline injection control). Permutated block
randomization into one of these four groups is done at the time point of
the ﬁrst aspiration. Blinding of patients and investigators is maintained
throughout the study. Serum, synovial ﬂuid and urine collection is
performed at the ﬁrst and second aspiration as well as at the time of ACLreconstruction. Synaﬂexor standardized ﬂexion weightbearing X-rays
are obtained on patients pre-operatively. Patient reported outcomes are
being collected at 6 time points up to 6months post-ACL reconstruction
with a focus on function and symptoms (IKDC, KOOS) activity level
(Marx-score), quality of life (KOOS-QOL, SF36) and pain (VAS, KOOS-
pain, Catastrophizing scale, CSQ).
Results: Only data from one cohort are available to date. Our practice
performs w 400 ACL reconstructions annually. Pre-study data showed
capture of 85.7% of all ACL injuries occurring in Fayette County: 66% of
patients were seen within 30 days after ACL injury; 37% were seen by a
Surgeon but 73% were seen by a Surgeon or PCP within 1 week of injury;
30% were seenwithin 4 days of injury. A total of 10 patients were eligible
for enrollment in a 4 month time period. After this pre-study data
changes were made to the study design including development of an
“early warning system” through physician extenders in high schools and
placement of additional physician extenders in the clinics to help with
enrollment. These changes allowed for enrollment of 30 patients in a 7
month time period, a 220% increase in enrollment numbers from the pre-
study period. 10–20% of all patients with ACL tears fulﬁll the inclusion
criteria. Screen failures occur at a rate of 25–30% due to either accom-
panying injuries (n ¼ 6) or patient refusal (n ¼ 4). No patient withdrew
from the study. One patient refused the second knee joint aspiration. No
patient was lost to follow-up. No problems were encountered regarding
the data collection, specimen storage or patient follow-up.
Conclusions: ACL patients can be recruited to a PTOA prevention trial
within 4 (þ 4) days after ACL injury if typical patient referral patterns
are changed. Even for a highly productive ACL practice it is imperative to
involve PCPs, Surgeons and outreach physician providers as stake
holders into the study. Early knee joint aspirations are well tolerated
and can be performed consecutively without patient withdrawals.
Patients report subjectively less pain after the aspirations. Few patients
refuse enrollment. Strict inclusion criteria result in a low number of
eligible patients (10–20% only). A careful pre-study analysis of referral
patterns, patient capture and environment is critical to perform
randomized clinical trials in this patient population.346
TUG AND FTSST IN KNEE OA PATIENTS SUBMITTED TO AN
EDUCATIONAL PROGRAM (PARQVE – PROJECT ARTHRITIS
RECOVERING QUALITY OF LIFE BY MEANS OF EDUCATION)
F.E. Farias, C.A. Silva, C.H. Cernigoy, M.U. Rezende, O.P. Camargo.
Faculdade Med. USP, Sao Paulo, Brazil
Purpose: Evaluate the improvement of function and balance in patients
with OA undergoing an educational program of a day with
multidisciplinary.
Methods: Two hundred and two patients with knee OAwere submitted
to two tests: Timed and Go (TUG) and Five Times Sit to Stand Test
(FTSST) at enrollment and one year after an educational program
(PARQVE). Patients were divided in four groups and received take home
written and audiovisual material on OA. Groups 1 to 3 had two days of
lectures with orthopedic surgeons, physical therapists, psychologists,
occupational therapists, nutritionist, physical educators, social workers.
Group 4 received the written and audio material. All patients were
oriented to exercise at least three times a week. Each group was sub-
divided in A (received bimonthly telephone calls) and B (no telephone
calls).
Results: All groups improved in TUG irrespective of the group theywere
in with no signiﬁcant difference between them (p ¼ 0.097). When
considering only groups 1 to 4, (irrespective of telephone calls) FTSST
showed a difference between groups (p ¼ 0.037), however ANOVA
could not show what group was different. But when comparing groups
that had classes (1þ2þ3) with the group that just received the educa-
tional material (4), TUG showed trends of difference p ¼ 0.066 and
FTSST improved signiﬁcantly in the class group p ¼ 0.012.
Conclusion: Patients improve function and balance with education and
attention.
